Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
05. Oktober 2022 17:00 ET
|
Biofrontera Inc.
WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced...
Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022
12. Juli 2022 08:00 ET
|
Biofrontera Inc.
WOBURN, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today...
Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022
06. April 2022 08:30 ET
|
Biofrontera Inc.
WOBURN, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today...